Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 2:00 AM
Study NCT ID:
NCT00790205
Status:
COMPLETED
Last Update Posted:
2021-11-23
First Post:
2008-11-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Sitagliptin Cardiovascular Outcomes Study (MK-0431-082)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-12-10
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2008-11-11
First Submit QC Date:
None
Study First Post Date:
2008-11-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-15
Results First Submit QC Date:
None
Results First Post Date:
2016-04-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-27
Last Update Post Date:
2021-11-23
Last Update Post Date Type:
ACTUAL